P0623 Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
Year: 2025
Type: conference-abstract
Source: Journal of Crohn s and Colitis
Authors: S Markovic, D Kralj, T Knezevic Ivanovski, A Kalaba, O Odanovic, A Homsek, P Svorcan, K Vucicevic, OPTYMAB studygroup
Institutions: Kliničko Bolnički Centar Zvezdara, University of Belgrade
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4406704530